425: Strive & Semler Merger: Cautionary Statement Filed

Strive, Inc. filed a Form 425 communication regarding its proposed business combination with Semler Scientific, Inc., emphasizing forward-looking statements and associated risks.

Summary

• A communication was posted on X.com by Ben Pham, Chief Financial Officer of Strive, Inc., on October 2, 2025, concerning the proposed business combination with Semler Scientific, Inc.
• The communication serves as a cautionary statement regarding forward-looking statements related to the merger, highlighting inherent risks and uncertainties.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and other relevant documents when they become available before making any voting or investment decisions.
• Strive, Semler Scientific, and certain of their respective directors, executive officers, and employees may be deemed participants in the solicitation of proxies from Semler Scientific stockholders.
• This communication does not constitute an offer to sell or a solicitation of an offer to buy any securities or a solicitation of any vote of approval.

Sentiment

Score: 5

Explanation: The filing is a standard legal disclosure for a proposed merger, primarily focused on outlining forward-looking statements and comprehensive risk factors. It maintains a neutral, cautious tone, as is typical for such regulatory documents, without expressing overt optimism or pessimism about the merger's success, beyond acknowledging potential benefits and significant risks.

Positives

• The proposed transaction is expected to yield strategic benefits for the combined company.
• The proposed transaction is expected to yield financial benefits for the combined company.

Negatives

• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Potential adverse reactions from customers or changes to business or employee relationships may arise from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price may occur before closing.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both of Strive and Semler Scientific to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact the transaction.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors, including unknown or unpredictable factors, could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The filing contains numerous forward-looking statements regarding the proposed transaction, including expectations for strategic and financial benefits, the timing of closing, and the ability to successfully integrate the combined businesses. However, these are subject to significant risks and uncertainties, and there is no assurance that actual results will not differ materially from projected future results.

Management Comments

• Ben Pham, Chief Financial Officer of Strive, Inc., posted this communication on X.com in connection with Strive's proposed business combination with Semler Scientific, Inc.

Industry Context

This filing relates to a proposed merger, a common strategic move in various industries for growth, market consolidation, or diversification. The explicit mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests that Strive or Semler Scientific, or the combined entity, has exposure or plans for digital asset integration, which represents a notable, albeit volatile, trend in corporate finance and investment strategies.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.

Stakeholder Impact

• Shareholders: Potential dilution from Strive's issuance of new shares; requirement for Semler Scientific stockholders to approve the transaction; potential changes in share price before closing.
• Customers: Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Employees: Potential changes to employee relationships resulting from the announcement or completion of the proposed transaction.
• Management: Diversion of management's attention from ongoing business operations and opportunities due to the transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, along with any other relevant documents filed with the SEC.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Bitcoin Treasury Strategy, Digital Assets, Proxy Solicitation